Business and Operation Excellence for Branded Generics Expansion into Emerging Markets
Overseas consumers respect and trust branded drugs more than local generics. Consumers perceive the latter as being satisfied with lax quality controls, while branded generics are trusted to have a higher level of quality and effectiveness. Branded generics are likely to reach up to 75 percent of sales growth in emerging markets within the next 10 years.
- New York, NY (1888PressRelease) October 28, 2011 - Cypin Production is pleased to announce it will host BRANDED GENERICS™: New Avenue for Rx Expansion into Emerging Markets. The conference will bring together leaders in the field of branded generics for a comprehensive overview of this rapidly expanding area of sales and development. The conference will be held in Philadelphia, Penn. from February 27-28, 2012 at the Hub Cira Center.
"Due to expiring patents, pharmaceutical manufacturers are expected to lose up to $180 billion in the U.S. in sales to generics over the next five years." said conference director Judy Tsui. "Branded generics products, if positioned carefully to the right market, could offer a new way for pharmaceutical manufacturers to actually broaden their sales. A Branded Generics conference is particularly important."
The conference is already off to a strong start, having garnered a renowned speaker faculty. Leading experts from China, India, Brazil, Mexico, Turkey, Russia, and Korea etc will discuss operation and business models for better market entry to specific markets. Among the companies whose experts on best practices will be featured: Merck & Co., Harvest Moon Pharmaceuticals USA, Abdi Ibrahim (Turkey), Parabolic Drugs Ltd. (India), R-Pharm (Russia), Generic Pharma 2.0, Ernst & Young, Deloitte, and Safeguard Scientifics, to name just a few.
The conference chairman will be Richard Dicicco, Chairman of Harvest Moon Pharmaceuticals USA. He will speak on "Branded Generics for Growth and Expansion into Emerging Markets."
Early-bird registration is already available. For more information on BRANDED GENERICS, or to register for the conference, please visit http://www.chinabrandedgeneric.com
For media requests, more information on Cypin Production, or if you are interested in sponsoring, exhibiting, or speaking opportunities with Cypin, please contact Judy Tsui at 917-338-7778 or judy ( @ ) cypinproduction dot com dot
ABOUT CYPIN PRODUCTION
Cypin Production is a third-party organizer that brings together government officials, leading biopharma practitioners, and academics in both China and America to share insights, expertise and solutions to today's escalating challenges in this industry. The company name is inspired by Cypin, a protein discovered by Rutgers scientists in 2004 that regulates nerve cell and neuron branching in the brain, an important process in helping people learn. Cypin makes a different kind of connection: bringing together potential buyers and sellers at our targeted conferences in emerging pharmaceutical/life science areas by providing face-to-face business opportunities and practical industry solutions for industry leaders through conferences and meetings.
###
space
space